<DOC>
	<DOCNO>NCT02554409</DOCNO>
	<brief_summary>The Sanofi Pasteur Fluzone Intradermal Quadrivalent vaccine ( Fluzone QIV-ID ) Pregnancy Registry prospectively recruit pregnancy surveillance program design collect collect analyze information vaccine exposure , pregnancy outcome , fetal offspring outcome pregnant woman expose Fluzone QIV-ID vaccine .</brief_summary>
	<brief_title>Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry</brief_title>
	<detailed_description>Sanofi Pasteur encourage registration pregnant woman expose Fluzone QIV-ID Sanofi Pasteur Pregnancy Registry provide registry 's toll-free number , 1-800-VACCINE ( 1-800-822-2463 ) , USPI . The toll-free number also available Sanofi Pasteur-sponsored Website Pregnancy Registry . Both United States product insert ( USPI ) Website advise health care provider register woman pregnant become aware pregnant time Fluzone QIV-ID immunization . Descriptive statistical method primary approach summarize data Fluzone QIV-ID Pregnancy Registry . No vaccine product provide administered part registry protocol .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Pregnant woman enrol registry prospectively ( exposure product conduct prenatal test could provide knowledge outcome pregnancy ) . If condition fetus already assess prenatal testing ( e.g. , targeted ultrasound , amniocentesis , etc . ) , report consider retrospective report . Retrospective report also eligible registry , analyze separately prospective report .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Fluzone Quadrivalent Intradermal Influenza Vaccine</keyword>
	<keyword>Pregnancy Registry</keyword>
	<keyword>Influenza</keyword>
</DOC>